Do COVID-19 Infectious Disease Models Incorporate the Social Determinants of Health? A Systematic Review
John-Baptiste A, Moulin M, Li Z, Hamilton D, Crichlow G, Klein D, Alemu F, Ghattas L, McDonald K, Asaria M, Sharpe C, Pandya E, Moqueet N, Champredon D, Moghadas S, Cooper L, Pinto A, Stranges S, Haworth-Brockman M, Galvani A, Ali S. Do COVID-19 Infectious Disease Models Incorporate the Social Determinants of Health? A Systematic Review. Public Health Reviews 2024, 45: 1607057. PMID: 39450316, PMCID: PMC11499127, DOI: 10.3389/phrs.2024.1607057.Peer-Reviewed Original ResearchSocial determinants of healthDeterminants of healthSocial determinantsAppraised study qualityWeb of ScienceStudy qualityTargeted interventionsStudy characteristicsPractice guidelinesCochrane LibraryRemote/rural locationsCOVID-19HealthUnited StatesMultiple countriesDifferential impactAgeRace/ethnicityMEDLINEEmbaseInterventionCochraneMathematical modeling studiesPandemicDisease modelsIncorporating Social Determinants of Health in Infectious Disease Models: A Systematic Review of Guidelines
Ali S, Li Z, Moqueet N, Moghadas S, Galvani A, Cooper L, Stranges S, Haworth-Brockman M, Pinto A, Asaria M, Champredon D, Hamilton D, Moulin M, John-Baptiste A. Incorporating Social Determinants of Health in Infectious Disease Models: A Systematic Review of Guidelines. Medical Decision Making 2024, 44: 742-755. PMID: 39305116, PMCID: PMC11491037, DOI: 10.1177/0272989x241280611.Peer-Reviewed Original ResearchSocial determinants of healthDeterminants of healthIncorporating social determinants of healthSocial determinantsSystematic review of guidelinesDisease riskHealth burdenPolicy impactImprove equitable accessSocial groupsImplementation challengesReview of guidelinesSocial heterogeneityImpact of infectious disease outbreaksSocioeconomic statusMitigation of disparitiesSystematic reviewEquitable accessDisease burdenEstimate policy impactsHealthID guidelinesInfectious disease outbreaksCOVID-19 pandemicDistributional impactsEvaluation of Strategies for Transitioning to Annual SARS-CoV-2 Vaccination Campaigns in the United States.
Wells C, Pandey A, Moghadas S, Fitzpatrick M, Singer B, Galvani A. Evaluation of Strategies for Transitioning to Annual SARS-CoV-2 Vaccination Campaigns in the United States. Annals Of Internal Medicine 2024, 177: 609-617. PMID: 38527289, DOI: 10.7326/m23-2451.Peer-Reviewed Original ResearchSARS-CoV-2 vaccination campaignSARS-CoV-2Centers for Disease Control and PreventionDisease Control and PreventionSARS-CoV-2 vaccinesHealth care costsVaccine-acquired immunityFood and Drug AdministrationU.S. Food and Drug AdministrationControl and PreventionNational Institutes of HealthVaccination campaignInfluenza vaccineInitial doseInstitutes of HealthSARS-CoV-2 variantsBooster doseImmune evasionDrug AdministrationUnited StatesNotsew Orm Sands FoundationDoseHealthPopulation immunityNational Institute